Adjuvant therapy with Imfinzi (durvalumab) and Imjudo (tremelimumab-actl) in patients with resected renal cell carcinoma was ...

Dutch-Turkish rapper Yukkie B, born Yuksel Ozince, died Sunday at the age of 56 from kidney cancer, his former partner ...

Investing.com -- Exelixis Inc. (NASDAQ:EXEL) shares fell 6.6% Monday after Merck announced its combination therapy outperformed Exelixis’ monotherapy Cabometyx in a late-stage kidney cancer trial.

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when ...

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing ...

At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...

Patients with advanced clear cell RCC whose disease progressed after 1-3 prior systemic therapies (including an anti–PD- [L]1 therapy) were randomly assigned 1:1 to belzutifan 200 mg or 120 mg daily: ...

Ethan Hughes scored an insurance goal in the second period, and the Spokane Chiefs downed the rival Tri-City Americans 5-2 in ...

SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease ...

According to Tang, this independence suggests that each biomarker provides unique prognostic information, making both valuable for understanding patient outcomes. Building on these findings, the ...

When 82-year-old Jack Smith steps onto the pickleball court, he plays to win. No stranger to competition, the lifelong ...